Department of Radiology, C-2S, Leiden University Medical Center, Albinusdreef 2, NL-2333 ZA, Leiden, The Netherlands.
Centre for Medical Sciences CISMed, University of Trento, 38122, Trento, Italy.
Eur Radiol. 2024 Jan;34(1):600-611. doi: 10.1007/s00330-023-10281-3. Epub 2023 Oct 7.
In 2014, for the first time, visible hyperintensities on unenhanced T1-weighted images in the nucleus dentatus and globus pallidus of the brain were associated with previous Gadolinium-based contrast agent (GBCA) injections and gadolinium deposition in patients with normal renal function. This led to a frenzy of retrospective studies with varying methodologies that the European Society of Magnetic Resonance in Medicine and Biology Gadolinium Research and Educational Committee (ESMRMB-GREC) summarised in 2019. Now, after 10 years, the members of the ESMRMB-GREC look backward and forward and review the current state of knowledge of gadolinium retention and deposition. CLINICAL RELEVANCE STATEMENT: Gadolinium deposition is associated with the use of linear GBCA but no clinical symptoms have been associated with gadolinium deposition. KEY POINTS : • Traces of Gadolinium-based contrast agent-derived gadolinium can be retained in multiple organs for a prolonged time. • Gadolinium deposition is associated with the use of linear Gadolinium-based contrast agents. • No clinical symptoms have been associated with gadolinium deposition.
2014 年,首次在肾功能正常的患者中发现脑内齿状核和苍白球的未增强 T1 加权图像上出现可见的高信号,与之前使用钆基造影剂(GBCA)注射和钆沉积有关。这导致了一系列回顾性研究的热潮,研究方法各不相同,欧洲磁共振医学与生物学学会(ESMRMB)的钆研究和教育委员会(Gadolinium Research and Educational Committee,GREC)在 2019 年对此进行了总结。现在,10 年过去了,ESMRMB-GREC 的成员回顾过去,展望未来,回顾了目前对钆保留和沉积的认识现状。临床相关性:钆沉积与线性 GBCA 的使用有关,但尚未发现与钆沉积有关的临床症状。要点:
Clin Transl Allergy. 2025-8
Arch Toxicol. 2025-7-3
Neurol Res Pract. 2025-5-19
Pharmaceutics. 2025-4-9
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025
Biochem Biophys Rep. 2022-1-28